Question of the Day

Question: What is NEPA?

Question: Who were the “radium girls”?

Question: What is the classic presentation of tick paralysis?

Question: What is “nanging” and what clinical symptoms may result from repeated nanging?

Question: Individuals requiring chronic transfusion therapy are often treated with the iron chelator deferoxamine in order to address transfusion-induced hemochromatosis and associated complications. Which toxicities have been associated with the use of deferoxamine?

Question: MEK inhibitors (inhibit the mitogen- activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) kinase) are a relatively new class of chemotherapeutic agents used in the treatment of a variety of metastatic cancers. These agents have been associated with the development of ocular toxicity. What is the nature of this toxicity?

Question: What is the elimination half-life of smoked crystal methamphetamine?

Question: How do electronic cigarettes produce the vapor inhaled by users of these products?

Question: Lithium is widely used as long-term therapy for bipolar disorder. What are the clinically important adverse risks for patients on long-term lithium therapy?

Question: What does the term “signal word”, as used by U.S. EPA, signify?